MICAFUNGIN-ZUSAMMENSETZUNGEN

European patent · EP3554474 · In force

Register entry

Publication number
EP3554474
Application number
EP17829412
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 15, 2017
Published
Oct 23, 2019
Granted
Dec 6, 2023
Protection ends at the latest
Dec 14, 2037
Next annual fee due
Dec 31, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 31/375 (2006.01)
Priority
US 201662435695 P 16.12.2016
PCT application
PCT/US2017/066652 15.12.2017
PCT publication
WO2018/112330 21.06.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Oct 16, 2024

    Change

    Published in Swissreg on 16.10.2024

  4. Jan 24, 2024

    Change

    Published in Swissreg on 24.01.2024

  5. Jan 19, 2024

    Agent entered

    Representative
    Kirker & Cie SA, Rue de Genève 122, CP 153, 1226 Genève-Thônex

    Published in Swissreg on 19.01.2024

  6. Dec 6, 2023

    Granted

    Published in Swissreg on 06.12.2023

Parties

Holder

Baxter Healthcare SA

Thurgauerstrasse 130, 8152 Glattpark (Opfikon)

Baxter International Inc.

One Baxter Parkway, Deerfield, IL 60015, US

Agent

Kirker & Cie SA

Rue de Genève 122 CP 153, 1226 Genève-Thônex

Inventor

DOTY, Mark J.

Grayslake, IL 60030, US

COPE, Sydney J.

Chicago, IL 60661, US

REBBECK, Christine L.

Lake Barrington, IL 60010, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.